Qualigen Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Qualigen Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2023.
  • Qualigen Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $1.31M, a 15% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $1.31M -$230K -15% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.36M -$226K -14.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $1.42M -$223K -13.6% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 $1.48M +$1.22M +460% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.54M +$1.21M +378% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.59M +$1.21M +322% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $1.65M +$1.21M +282% Dec 31, 2021 10-K 2023-05-02
Q3 2021 $264K -$220K -45.4% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $321K -$214K -40% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $377K +$311K +474% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $431K +$338K +363% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $484K +$364K +303% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $535K +$389K +265% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $65.6K -$107K -62% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $93K Dec 31, 2019 10-Q 2020-05-01
Q3 2019 $120K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $147K Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $173K Mar 31, 2019 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.